中文 | EN | 日本語
Financial Reports Latest Updates Industry Maps Economic Calendar

Citius Pharmaceuticals, Inc. (CTXR) Current Reports & Earnings Releases

View full earnings calendar →

Upcoming

FiledFormItemsFiling
2026-08-21 8-K Listing Notice SEC
2026-08-14 8-K Results of Operations, Financial Statements & Exhibits SEC
2026-08-05 8-K Other Events, Financial Statements & Exhibits SEC
2026-06-01 8-K Other Events, Financial Statements & Exhibits SEC
2026-05-15 8-K Results of Operations, Financial Statements & Exhibits SEC
2026-05-08 8-K Material Agreement, Financial Statements & Exhibits SEC
2026-04-29 8-K Unregistered Sales, Other Events, Financial Statements & Exhibits SEC
2026-04-24 8-K Material Agreement, Other Events, Financial Statements & Exhibits SEC
2026-04-06 8-K Shareholder Vote Results SEC
2026-03-31 8-K Other Events, Financial Statements & Exhibits SEC
2026-03-10 8-K Other Events, Financial Statements & Exhibits SEC
2026-03-04 8-K Other Events, Financial Statements & Exhibits SEC
2026-02-13 8-K Results of Operations, Listing Notice, Financial Statements & Exhibits SEC
2025-12-23 8-K Results of Operations, Financial Statements & Exhibits SEC
2025-12-01 8-K Reg FD Disclosure, Other Events, Financial Statements & Exhibits SEC
2025-10-23 8-K Reg FD Disclosure, Financial Statements & Exhibits SEC
2025-10-21 8-K Material Agreement, Other Events, Financial Statements & Exhibits SEC
2025-08-12 8-K Results of Operations, Financial Statements & Exhibits SEC
2025-07-08 8-K Other Events, Financial Statements & Exhibits SEC
2025-06-12 8-K Material Agreement, Other Events, Financial Statements & Exhibits SEC
2025-06-09 8-K Item 3.03, Charter Amendments, Shareholder Vote Results, Financial Statements & Exhibits SEC
2025-06-03 8-K Material Agreement, Direct Financial Obligation, Financial Statements & Exhibits SEC
2025-05-30 8-K Listing Notice SEC
2025-05-14 8-K Results of Operations, Financial Statements & Exhibits SEC
2025-04-18 8-K Material Agreement, Unregistered Sales, Item 3.03, Charter Amendments, Financial Statements & Exhibits SEC
2025-04-03 8-K Material Agreement, Financial Statements & Exhibits SEC
2025-04-02 8-K Material Agreement, Other Events, Financial Statements & Exhibits SEC
2025-03-10 8-K Shareholder Vote Results SEC
2025-02-14 8-K Other Events, Financial Statements & Exhibits SEC
2025-02-06 8-K Other Events, Financial Statements & Exhibits SEC
2025-01-08 8-K Material Agreement, Other Events, Financial Statements & Exhibits SEC
2025-01-07 8-K Other Events, Financial Statements & Exhibits SEC
2024-12-27 8-K Results of Operations, Financial Statements & Exhibits SEC
2024-12-20 8-K Other Events SEC
2024-11-26 8-K Item 3.03, Charter Amendments, Other Events, Financial Statements & Exhibits SEC
2024-11-25 8-K Other Events, Financial Statements & Exhibits SEC
2024-11-18 8-K Material Agreement, Other Events, Financial Statements & Exhibits SEC
2024-11-13 8-K Listing Notice SEC
2024-11-12 8-K Other Events, Financial Statements & Exhibits SEC
2024-09-27 8-K Material Agreement SEC
2024-09-13 8-K Material Agreement SEC
2024-09-11 8-K Listing Notice SEC
2024-09-05 8-K Other Events, Financial Statements & Exhibits SEC
2024-08-16 8-K Material Agreement, Direct Financial Obligation, Other Events, Financial Statements & Exhibits SEC
2024-08-12 8-K Results of Operations, Financial Statements & Exhibits SEC
2024-08-08 8-K Other Events, Financial Statements & Exhibits SEC
2024-05-21 8-K Other Events, Financial Statements & Exhibits SEC
2024-05-14 8-K Results of Operations, Financial Statements & Exhibits SEC
2024-04-30 8-K Material Agreement, Other Events, Financial Statements & Exhibits SEC
2024-04-05 8-K Other Events SEC
2024-03-18 8-K Other Events, Financial Statements & Exhibits SEC
2024-03-13 8-K Listing Notice, Shareholder Vote Results SEC
2024-02-15 8-K Results of Operations, Financial Statements & Exhibits SEC
2024-02-14 8-K Other Events, Financial Statements & Exhibits SEC
2024-01-23 8-K Other Events, Financial Statements & Exhibits SEC
2024-01-05 8-K Item 5.08 SEC
2024-01-02 8-K Results of Operations, Other Events, Financial Statements & Exhibits SEC

Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.